{
 "PrintNo":"S320","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2020-12-28T16:03:00.911971Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-01-06","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1228,"Name":"Zellnor Myrie","Short":"MYRIE"}],
 "Title":"Relates to investigating critical prescription drug pricing",
 "Summary":"Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing.",
 "LawSection":"Insurance Law","LawCode":"Add ยง346, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to investigating critical prescription drug pricing",
 "PreviousVersions":["S7739-2019"]
}